News - BioPharm International

ADVERTISEMENT

News

Amgen Sues Sanofi and Regeneron over Patent for mAb Targeting PCSK9

October 20, 2014

A Priority Review voucher Sanofi and Regeneron purchased from BioMarin pharmaceuticals may put their mAb ahead of Amgen's in the market.

EMA Works to Speed Up Ebola Treatment

October 20, 2014

The agency recommends that companies developing drugs to treat Ebola apply for orphan drug designation.

AbbVie/Shire Deal Officially Off

October 20, 2014

AbbVie to pay Shire $1.636 billion break fee for terminating purchase agreement.

BioReliance Introduces New Predictive Assays

October 17, 2014

The new service offering will help customers determine levels of permeability, transport, metabolism, and toxicity in drug product.

Lilly to Close Manufacturing Facility in Puerto Rico

October 17, 2014

Lilly announces the closure of its Guayama, Puerto Rico manufacturing facility amid continued investments at other plants.

Harnessing the Power of Modified T Cells to Treat Cancer

October 17, 2014

Personalized immunotherapy treatments help 90% of acute lymphoblastic leukemia patients achieve remission in a new study.

Industry Stakeholders Tackle the Use of Biological Qualifiers at WHO Naming Session

October 16, 2014

Many European biosimilar groups argue that biological qualifiers should not be implemented in countries where the brand name or INN of a drug is already well established.

Pfizer Ireland Plant Receives ISPE Award

October 16, 2014

Pfizer's addition of a new vaccine suite and multiproduct bioprocess suite to its Ireland facility win the company the title of 2014 Facility of the Year.

AbbVie Reconsiders Shire Offer

October 15, 2014

AbbVie sends Shire notice that it is reconsidering its offer recommendation.

ADVERTISEMENT

ADVERTISEMENT

Click here